{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:42:58Z","timestamp":1785415378146,"version":"3.56.0"},"reference-count":51,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007700","name":"Carol Davila University of Medicine and Pharmacy","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007700","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/04fm87419","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Neoadjuvant chemoradiotherapy is a key component of the treatment strategy for locally advanced rectal cancer (LARC), both through its direct impact on oncological prognosis and by increasing the likelihood of sphincter-preserving surgery. Oncological prognosis improves dramatically following a complete pathological response to neoadjuvant therapy. Identifying predictors of response to neoadjuvant therapy has been a challenge over the past two decades, and these factors have not been fully identified. This study aimed to analyze the clinical, biological, and therapeutic factors associated with tumor response following neoadjuvant therapy in patients with locally advanced rectal cancer, with the aim of identifying independent predictors of the absence of a complete pathological response and optimizing personalized treatment strategies. Materials and Methods: This retrospective study included a cohort of 122 patients (81 men and 41 women), with a mean age of 63.5 years, diagnosed with locally advanced rectal cancer at two centers with expertise in colorectal surgery between January 2018 and December 2023. Patients received neoadjuvant treatment in two regimens: long-course chemoradiotherapy with oral radiosensitizing chemotherapy (82 patients) and total neoadjuvant therapy consisting of chemoradiotherapy followed by consolidation chemotherapy (40 patients). A series of clinical, biological, and therapeutic variables was analyzed for their association with pathological responses. Results: According to the Ryan score, the overall complete response rate following neoadjuvant therapy was 17.2%. pCR was observed more frequently in patients treated with total neoadjuvant therapy than in those treated with standard chemoradiotherapy. Elevated pre-treatment CEA levels were independently associated with a higher risk of unfavorable tumor response. The radiation dose and interval between completion of radiotherapy and surgery were significantly associated with tumor regression. Conclusions: These results underscore the importance of personalizing neoadjuvant therapy to improve cancer prognosis. Furthermore, optimizing tumor regression could lead to the potential expansion of sphincter-preserving resection techniques, which would have a direct and significant impact on the quality of life of these patients.<\/jats:p>","DOI":"10.3390\/medicina62040793","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:57:21Z","timestamp":1776758241000},"page":"793","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoadjuvant Therapy in Locally Advanced Rectal Cancer\u2014What Result Should We Expect?"],"prefix":"10.3390","volume":"62","author":[{"given":"Roxana-Elena","family":"Stefan","sequence":"first","affiliation":[{"name":"Doctoral School, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of General and Esophageal Surgery, Sf. Maria Clinical Hospital, 011192 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Constantin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of General and Esophageal Surgery, Sf. Maria Clinical Hospital, 011192 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Dinu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of General and Esophageal Surgery, Sf. Maria Clinical Hospital, 011192 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0095-494X","authenticated-orcid":false,"given":"Florin","family":"Achim","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of General and Esophageal Surgery, Sf. Maria Clinical Hospital, 011192 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Rotariu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of General and Esophageal Surgery, Sf. Maria Clinical Hospital, 011192 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Grama","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of General Surgery, Coltea Clinical Hospital, 030167 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5517-5340","authenticated-orcid":false,"given":"Horia-Dan","family":"Liscu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Radiotherapy, Emergency University Hospital, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7771-1606","authenticated-orcid":false,"given":"Lucian","family":"Iordache","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Radiotherapy, Coltea Clinical Hospital, 030167 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos-Viorel","family":"Scripcariu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"First Oncological Surgery Unit, Regional Institute of Oncology, 700483 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Rasuceanu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of General and Esophageal Surgery, Sf. Maria Clinical Hospital, 011192 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silviu","family":"Constantinoiu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of General and Esophageal Surgery, Sf. Maria Clinical Hospital, 011192 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4495-0828","authenticated-orcid":false,"given":"Dragos","family":"Predescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of General and Esophageal Surgery, Sf. Maria Clinical Hospital, 011192 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2468-1253(19)30147-5","article-title":"Changes in colorectal cancer incidence in seven high-income countries: A population-based study","volume":"4","author":"Araghi","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41575-024-00900-9","article-title":"Future direction of total neoadjuvant therapy for locally advanced rectal cancer","volume":"21","author":"Kagawa","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","first-page":"iv22","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Wyrwicz","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bjs.1800691019","article-title":"The mesorectum in rectal cancer surgery\u2014The clue to pelvic recurrence?","volume":"69","author":"Heald","year":"1982","journal-title":"Br. J. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","article-title":"Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer","volume":"23","author":"Martus","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Akkaya, H., Dilek, O., \u00d6zdemir, S., \u00d6zt\u00fcrk\u00e7\u00fc, T., G\u00fcrb\u00fcz, M., Tas, Z.A., \u00c7etink\u00fcnar, S., and G\u00fclek, B. (2024). Rectal Cancer and Lateral Lymph Node Staging: Interobserver Agreement and Success in Predicting Locoregional Recurrence. Diagnostics, 14.","DOI":"10.3390\/diagnostics14222570"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br. J. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","article-title":"Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Benson","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41575-020-0275-y","article-title":"The multidisciplinary management of rectal cancer","volume":"17","author":"Keller","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"djx095","DOI":"10.1093\/jnci\/djx095","article-title":"Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer","volume":"109","author":"Fokas","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy","volume":"12","author":"Dworak","year":"1997","journal-title":"Int. J. Colorectal. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e180071","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): A multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/SLA.0b013e3181b91e63","article-title":"Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer","volume":"250","author":"Kalady","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/DCR.0b013e31828e5a72","article-title":"CEA-a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer","volume":"56","author":"Wallin","year":"2013","journal-title":"Dis. Colon Rectum"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1748-717X-8-43","article-title":"Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery","volume":"8","author":"Yang","year":"2013","journal-title":"Radiat. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jso.20320","article-title":"Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer","volume":"93","author":"Park","year":"2006","journal-title":"J. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kim, I.Y., You, S.H., and Kim, Y.W. (2014). Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer. BMC Surg., 14.","DOI":"10.1186\/1471-2482-14-94"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/DCR.0b013e3182a25c4e","article-title":"Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer: Are We Getting Closer to Anal Cancer Management?","volume":"56","author":"Sabbaga","year":"2013","journal-title":"Dis. Colon Rectum"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jamcollsurg.2015.04.010","article-title":"Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation","volume":"221","author":"Probst","year":"2015","journal-title":"J. Am. Coll. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1245\/s10434-017-5873-8","article-title":"Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database","volume":"24","author":"Lorimer","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kokaine, L., Gardovskis, A., and Gardovskis, J. (2021). Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy. Medicina, 57.","DOI":"10.3390\/medicina57101044"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jso.25355","article-title":"Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB","volume":"119","author":"Chapman","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1007\/s00464-008-9976-y","article-title":"Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience","volume":"22","author":"Guerrieri","year":"2008","journal-title":"Surg. Endosc."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lo Greco, M.C., La Rocca, M., Marano, G., Finocchiaro, I., Liardo, R.L.E., Milazzotto, R., Acquaviva, G., Basile, A., Palmucci, S., and Foti, P.V. (2023). Integrated Intensified Chemoradiation in the Setting of Total Neoadjuvant Therapy (TNT) in Patients with Locally Advanced Rectal Cancer: A Retrospective Single-Arm Study on Feasibility and Efficacy. Cancers, 15.","DOI":"10.3390\/cancers15030921"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sclafani, F., Corr\u00f2, C., and Koessler, T. (2021). Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer. Cancers, 13.","DOI":"10.3390\/cancers13246361"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11547-019-01007-x","article-title":"Trends in combined radio-chemotherapy for locally advanced rectal cancer: A survey among radiation oncology centers of Sicily region on behalf of AIRO","volume":"124","author":"Spatola","year":"2019","journal-title":"Radiol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2014.08.035","article-title":"Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: A systematic review and meta-analysis","volume":"113","author":"Burbach","year":"2014","journal-title":"Radiother. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2011.06.2008","article-title":"Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial","volume":"83","author":"Arbea","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1748-717X-9-70","article-title":"Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II\/III rectal adenocarcinoma: Results of a phase II study","volume":"9","author":"Zhu","year":"2014","journal-title":"Radiat. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12029-013-9546-y","article-title":"Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer","volume":"45","author":"Russo","year":"2014","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/SLA.0000000000000368","article-title":"Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies","volume":"263","author":"Petrelli","year":"2016","journal-title":"Ann. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11605-010-1197-8","article-title":"Neoadjuvant therapy for rectal cancer: The impact of longer interval between chemoradiation and surgery","volume":"15","author":"Geisler","year":"2011","journal-title":"J. Gastrointest. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1245\/s10434-008-9892-3","article-title":"An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer","volume":"15","author":"Tulchinsky","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10350-004-6579-0","article-title":"Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma","volume":"46","author":"Stein","year":"2003","journal-title":"Dis. Colon Rectum"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/bjs.9112","article-title":"Dutch Surgical Colorectal Audit. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer","volume":"100","author":"Sloothaak","year":"2013","journal-title":"Br. J. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"15330338231202893","DOI":"10.1177\/15330338231202893","article-title":"A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma","volume":"22","author":"Qing","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_47","first-page":"77","article-title":"Analyses of predictive factors for pathological complete remission in neoadjuvant therapy for locally advanced rectal cancer","volume":"24","author":"Yang","year":"2019","journal-title":"J. Balk. Union Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.21873\/anticanres.13067","article-title":"Predicting pathological complete regression with haematological markers during neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"38","author":"Lee","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Yan, L., Wu, Y., Xu, M., Liu, X., and Guan, G. (2020). Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07359-2"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.7150\/jca.25493","article-title":"Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"9","author":"Peng","year":"2018","journal-title":"J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/DCR.0b013e3182707e47","article-title":"Response to neoadjuvant therapy in patients with early age-of-onset rectal cancer","volume":"56","author":"Steinhagen","year":"2013","journal-title":"Dis. Colon Rectum"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/793\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:17:10Z","timestamp":1776917830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["medicina62040793"],"URL":"https:\/\/doi.org\/10.3390\/medicina62040793","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}